nodes	percent_of_prediction	percent_of_DWPC	metapath
Neomycin—Acarbose—type 2 diabetes mellitus	0.609	1	CrCtD
Neomycin—Framycetin—Acarbose—type 2 diabetes mellitus	0.105	0.288	CrCrCtD
Neomycin—Paromomycin—Acarbose—type 2 diabetes mellitus	0.094	0.259	CrCrCtD
Neomycin—Amikacin—Acarbose—type 2 diabetes mellitus	0.0855	0.236	CrCrCtD
Neomycin—Kanamycin—Acarbose—type 2 diabetes mellitus	0.0786	0.217	CrCrCtD
Neomycin—Glaucoma—Gliclazide—type 2 diabetes mellitus	0.00074	0.0263	CcSEcCtD
Neomycin—Viral infection—Gliclazide—type 2 diabetes mellitus	0.000617	0.0219	CcSEcCtD
Neomycin—Erythema—Tolbutamide—type 2 diabetes mellitus	0.000584	0.0208	CcSEcCtD
Neomycin—Viral infection—Valsartan—type 2 diabetes mellitus	0.000567	0.0202	CcSEcCtD
Neomycin—Erythema—Tolazamide—type 2 diabetes mellitus	0.000532	0.0189	CcSEcCtD
Neomycin—Erythema—Acarbose—type 2 diabetes mellitus	0.000511	0.0181	CcSEcCtD
Neomycin—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000429	0.0153	CcSEcCtD
Neomycin—Infection—Linagliptin—type 2 diabetes mellitus	0.000427	0.0152	CcSEcCtD
Neomycin—Erythema—Repaglinide—type 2 diabetes mellitus	0.000426	0.0151	CcSEcCtD
Neomycin—Swelling—Valsartan—type 2 diabetes mellitus	0.000421	0.015	CcSEcCtD
Neomycin—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000363	0.0129	CcSEcCtD
Neomycin—Swelling—Irbesartan—type 2 diabetes mellitus	0.000362	0.0129	CcSEcCtD
Neomycin—Erythema—Glipizide—type 2 diabetes mellitus	0.000353	0.0125	CcSEcCtD
Neomycin—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000348	0.0124	CcSEcCtD
Neomycin—Swelling—Losartan—type 2 diabetes mellitus	0.000341	0.0121	CcSEcCtD
Neomycin—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000337	0.012	CcSEcCtD
Neomycin—Erythema—Glimepiride—type 2 diabetes mellitus	0.000329	0.0117	CcSEcCtD
Neomycin—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000329	0.0117	CcSEcCtD
Neomycin—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000327	0.0116	CcSEcCtD
Neomycin—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000316	0.0112	CcSEcCtD
Neomycin—Nausea—Miglitol—type 2 diabetes mellitus	0.000315	0.0112	CcSEcCtD
Neomycin—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000307	0.0109	CcSEcCtD
Neomycin—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000307	0.0109	CcSEcCtD
Neomycin—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000307	0.0109	CcSEcCtD
Neomycin—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000297	0.0105	CcSEcCtD
Neomycin—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000296	0.0105	CcSEcCtD
Neomycin—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000294	0.0104	CcSEcCtD
Neomycin—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000285	0.0101	CcSEcCtD
Neomycin—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000284	0.0101	CcSEcCtD
Neomycin—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000283	0.0101	CcSEcCtD
Neomycin—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000276	0.0098	CcSEcCtD
Neomycin—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000276	0.0098	CcSEcCtD
Neomycin—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000275	0.00977	CcSEcCtD
Neomycin—Infection—Pioglitazone—type 2 diabetes mellitus	0.000274	0.00973	CcSEcCtD
Neomycin—Erythema—Glyburide—type 2 diabetes mellitus	0.000271	0.00964	CcSEcCtD
Neomycin—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000269	0.00954	CcSEcCtD
Neomycin—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000268	0.00951	CcSEcCtD
Neomycin—Infection—Sitagliptin—type 2 diabetes mellitus	0.000266	0.00945	CcSEcCtD
Neomycin—Vomiting—Acarbose—type 2 diabetes mellitus	0.000265	0.00942	CcSEcCtD
Neomycin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000258	0.00916	CcSEcCtD
Neomycin—Nausea—Tolazamide—type 2 diabetes mellitus	0.000258	0.00916	CcSEcCtD
Neomycin—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000256	0.00911	CcSEcCtD
Neomycin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000256	0.00908	CcSEcCtD
Neomycin—Nausea—Acarbose—type 2 diabetes mellitus	0.000248	0.0088	CcSEcCtD
Neomycin—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000246	0.00875	CcSEcCtD
Neomycin—Erythema—Gliclazide—type 2 diabetes mellitus	0.000244	0.00866	CcSEcCtD
Neomycin—Infection—Bromocriptine—type 2 diabetes mellitus	0.000241	0.00855	CcSEcCtD
Neomycin—Nausea—Nateglinide—type 2 diabetes mellitus	0.000239	0.00848	CcSEcCtD
Neomycin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000238	0.00846	CcSEcCtD
Neomycin—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000233	0.00827	CcSEcCtD
Neomycin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000225	0.00799	CcSEcCtD
Neomycin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000221	0.00786	CcSEcCtD
Neomycin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000212	0.00753	CcSEcCtD
Neomycin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000207	0.00734	CcSEcCtD
Neomycin—Erythema—Metformin—type 2 diabetes mellitus	0.000204	0.00725	CcSEcCtD
Neomycin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000204	0.00724	CcSEcCtD
Neomycin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00722	CcSEcCtD
Neomycin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000198	0.00703	CcSEcCtD
Neomycin—Infection—Gliclazide—type 2 diabetes mellitus	0.000198	0.00702	CcSEcCtD
Neomycin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00701	CcSEcCtD
Neomycin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000197	0.007	CcSEcCtD
Neomycin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000195	0.00694	CcSEcCtD
Neomycin—Erythema—Irbesartan—type 2 diabetes mellitus	0.000192	0.00684	CcSEcCtD
Neomycin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00019	0.00675	CcSEcCtD
Neomycin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000189	0.0067	CcSEcCtD
Neomycin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000184	0.00653	CcSEcCtD
Neomycin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000183	0.00651	CcSEcCtD
Neomycin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000183	0.0065	CcSEcCtD
Neomycin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000183	0.00649	CcSEcCtD
Neomycin—Infection—Valsartan—type 2 diabetes mellitus	0.000182	0.00645	CcSEcCtD
Neomycin—Erythema—Losartan—type 2 diabetes mellitus	0.000181	0.00643	CcSEcCtD
Neomycin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000181	0.00642	CcSEcCtD
Neomycin—Infection—Orlistat—type 2 diabetes mellitus	0.000179	0.00637	CcSEcCtD
Neomycin—Nausea—Glipizide—type 2 diabetes mellitus	0.000171	0.00607	CcSEcCtD
Neomycin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000171	0.00607	CcSEcCtD
Neomycin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00017	0.00605	CcSEcCtD
Neomycin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00589	CcSEcCtD
Neomycin—Infection—Metformin—type 2 diabetes mellitus	0.000165	0.00587	CcSEcCtD
Neomycin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000163	0.0058	CcSEcCtD
Neomycin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00016	0.00567	CcSEcCtD
Neomycin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000159	0.00565	CcSEcCtD
Neomycin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000157	0.00558	CcSEcCtD
Neomycin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000157	0.00557	CcSEcCtD
Neomycin—Infection—Irbesartan—type 2 diabetes mellitus	0.000156	0.00554	CcSEcCtD
Neomycin—Erythema—Ramipril—type 2 diabetes mellitus	0.000155	0.00552	CcSEcCtD
Neomycin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00547	CcSEcCtD
Neomycin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000152	0.00539	CcSEcCtD
Neomycin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000148	0.00525	CcSEcCtD
Neomycin—Infection—Losartan—type 2 diabetes mellitus	0.000147	0.00522	CcSEcCtD
Neomycin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000147	0.00521	CcSEcCtD
Neomycin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000144	0.00511	CcSEcCtD
Neomycin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000141	0.005	CcSEcCtD
Neomycin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000141	0.005	CcSEcCtD
Neomycin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000136	0.00484	CcSEcCtD
Neomycin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000135	0.00478	CcSEcCtD
Neomycin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000133	0.00473	CcSEcCtD
Neomycin—Nausea—Glyburide—type 2 diabetes mellitus	0.000132	0.00468	CcSEcCtD
Neomycin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000129	0.00459	CcSEcCtD
Neomycin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000128	0.00454	CcSEcCtD
Neomycin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000127	0.0045	CcSEcCtD
Neomycin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000126	0.00449	CcSEcCtD
Neomycin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000125	0.00444	CcSEcCtD
Neomycin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000124	0.00439	CcSEcCtD
Neomycin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000118	0.0042	CcSEcCtD
Neomycin—Pruritus—Metformin—type 2 diabetes mellitus	0.000118	0.00418	CcSEcCtD
Neomycin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000116	0.00413	CcSEcCtD
Neomycin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000116	0.00411	CcSEcCtD
Neomycin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000115	0.00408	CcSEcCtD
Neomycin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000114	0.00405	CcSEcCtD
Neomycin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000111	0.00395	CcSEcCtD
Neomycin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000109	0.00387	CcSEcCtD
Neomycin—Nausea—Valsartan—type 2 diabetes mellitus	0.000109	0.00386	CcSEcCtD
Neomycin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000107	0.00382	CcSEcCtD
Neomycin—Nausea—Orlistat—type 2 diabetes mellitus	0.000107	0.00381	CcSEcCtD
Neomycin—Vomiting—Metformin—type 2 diabetes mellitus	0.000106	0.00376	CcSEcCtD
Neomycin—Pruritus—Losartan—type 2 diabetes mellitus	0.000105	0.00372	CcSEcCtD
Neomycin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000101	0.00359	CcSEcCtD
Neomycin—Vomiting—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.00355	CcSEcCtD
Neomycin—Nausea—Metformin—type 2 diabetes mellitus	9.88e-05	0.00351	CcSEcCtD
Neomycin—Vomiting—Losartan—type 2 diabetes mellitus	9.4e-05	0.00334	CcSEcCtD
Neomycin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.34e-05	0.00332	CcSEcCtD
Neomycin—Nausea—Irbesartan—type 2 diabetes mellitus	9.33e-05	0.00331	CcSEcCtD
Neomycin—Pruritus—Ramipril—type 2 diabetes mellitus	8.97e-05	0.00319	CcSEcCtD
Neomycin—Nausea—Losartan—type 2 diabetes mellitus	8.78e-05	0.00312	CcSEcCtD
Neomycin—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.67e-05	0.00308	CcSEcCtD
Neomycin—Vomiting—Ramipril—type 2 diabetes mellitus	8.06e-05	0.00286	CcSEcCtD
Neomycin—Nausea—Ramipril—type 2 diabetes mellitus	7.53e-05	0.00267	CcSEcCtD
